Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vitiligo: Mechanisms of Pathogenesis and Treatment
Michael L. Frisoli, Kingsley I. Essien, John E. Harris
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 621-648
Closed Access | Times Cited: 383

Showing 1-25 of 383 citing articles:

Mechanisms of melanocyte death in vitiligo
Jianru Chen, Shuli Li, Chunying Li
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 1138-1166
Open Access | Times Cited: 187
Vitiligo: A focus on pathogenesis and its therapeutic implications
Christina Bergqvist, Khaled Ezzedine
The Journal of Dermatology (2021) Vol. 48, Iss. 3, pp. 252-270
Closed Access | Times Cited: 186
Anatomically distinct fibroblast subsets determine skin autoimmune patterns
Zijian Xu, Daoming Chen, Yucheng Hu, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 118-124
Closed Access | Times Cited: 159
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
Qi Fei, Fang Liu, Ling Gao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 115
Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment
Khatereh Khorsandi, Reza Hosseinzadeh, HomaSadat Esfahani, et al.
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 93
The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death
Yijie Xuan, Yiwen Yang, Leihong Xiang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 89
Update on the pathogenesis of vitiligo
Helena Zenedin Marchioro, Caio César Silva de Castro, Vinicius M. Fava, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 4, pp. 478-490
Open Access | Times Cited: 83
Exosomes: The emerging mechanisms and potential clinical applications in dermatology
Honghao Yu, Heting Feng, Hong Zeng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1778-1795
Open Access | Times Cited: 20
A Review of the Pharmacological Properties of Psoralen
Yali Ren, Xiaominting Song, Lu Tan, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 94
scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T reg function
Kyle Gellatly, James P. Strassner, Kingsley I. Essien, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 610
Open Access | Times Cited: 76
Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo
Yinghan Wang, Shuli Li, Chunying Li
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 299-323
Closed Access | Times Cited: 60
Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo
Pan Kang, Jianru Chen, Weigang Zhang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 43
Beyond skin white spots: Vitiligo and associated comorbidities
Zhonghui Hu, Tao Wang
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 30
Ferroptosis: Mechanism and connections with cutaneous diseases
Lihao Liu, Ni Lian, Liqing Shi, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 22
Melanin Biopolymers in Pharmacology and Medicine—Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy
Marta Karkoszka, Jakub Rok, Dorota Wrześniok
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 521-521
Open Access | Times Cited: 12
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study
Thierry Passeron, Khaled Ezzedine, Iltefat Hamzavi, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102655-102655
Open Access | Times Cited: 10
3D‐hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells‐Mediated Immunosuppression and Suppressing Oxidative Stress‐Induced Melanocyte Damage
Qi Wang, Weinan Guo, Liaoran Niu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 9
Management of the refractory vitiligo patient: current therapeutic strategies and future options
Xinju Wang, Wei Wu, Jianru Chen, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
Zhussipbek Mukhatayev, Emilia R. Dellacecca, Cormac Cosgrove, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 55
Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors
Safa Faraj, E. Helen Kemp, David J. Gawkrodger
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 1, pp. 27-43
Open Access | Times Cited: 52
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
Christina Martins, Laure Migayron, Claire Drullion, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1194-1205.e7
Open Access | Times Cited: 45
Translational Research in Vitiligo
Erica L. Katz, John E. Harris
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Current Concepts of Vitiligo Immunopathogenesis
Nika Hlača, Tina Žagar, Marija Kaštelan, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1639-1639
Open Access | Times Cited: 34
Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
Jie Dong, Xuan Huang, Li-Ping Ma, et al.
Dose-Response (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 30
Combining network pharmacology, molecular docking, molecular dynamics simulation, and experimental verification to examine the efficacy and immunoregulation mechanism of FHB granules on vitiligo
Xiaolong Li, Fengze Miao, Rujuan Xin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top